A multicentre, retrospective chart review study to describe the clinical profile of idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib (OFEVĀ®) in real-world practice in Spain (BROAD)

01/06/2017
31/03/2024
EU PAS number:
EUPAS19384
Study
Finalised
Documents
Study protocol
Study results
Study results
English (658.69 KB - PDF) View document
Study report
Other information